Mohamed Lazzouni
CIK 1320180 · View on SEC EDGAR ↗
First SEC filing: Nov. 4, 2024 · Latest: Nov. 4, 2024
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 3, 2022 | AWRE | P | 5,000 | $2.15 | $10,750 | 40,907 Direct | +13.92% | Acquired | -43.7% (price as of 2026-08-21) |
| May 16, 2022 | AWRE | P | 5,000 | $2.68 | $13,400 | 28,392 Direct | +21.37% | Acquired | -54.9% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 31, 2024 | AWRE | Stock Option (Right to Buy) | Common Stock (150,000) | $2.05 | Oct. 31, 2034 | 150,000 | Acquired |
| Feb. 20, 2024 | AWRE | Stock Option (Right to Buy) | Common Stock (157,873) | $2.21 | Nov. 19, 2029 | 157,873 | Acquired |
| Feb. 20, 2024 | AWRE | Stock Option (Right to Buy) | Common Stock (18,750) | $7.50 | Nov. 19, 2029 | 18,750 | Disposed |
| Feb. 20, 2024 | AWRE | Stock Option (Right to Buy) | Common Stock (18,750) | $6.50 | Nov. 19, 2029 | 18,750 | Disposed |
| Feb. 20, 2024 | AWRE | Stock Option (Right to Buy) | Common Stock (18,750) | $5.50 | Nov. 19, 2029 | 18,750 | Disposed |
| Feb. 20, 2024 | AWRE | Stock Option (Right to Buy) | Common Stock (18,750) | $4.50 | Nov. 19, 2029 | 18,750 | Disposed |
| Feb. 20, 2024 | AWRE | Stock Option (Right to Buy) | Common Stock (300,000) | $4.73 | Feb. 23, 2031 | 300,000 | Disposed |
| March 1, 2022 | AWRE | Unrestricted Stock Award | Common Stock (20,000) | $0.00 | — | 20,000 | Acquired |
| Feb. 24, 2021 | AWRE | Stock Option (right to buy) | Common Stock (300,000) | $4.73 | Feb. 23, 2031 | 300,000 | Acquired |
| Nov. 19, 2020 | AWRE | Unrestricted Stock Award | Common Stock (10,000) | $0.00 | — | 10,000 | Acquired |
| June 30, 2020 | AWRE | Unrestricted Stock Award | Common Stock (12,500) | $0.00 | — | 12,500 | Disposed |
| May 4, 2020 | AWRE | Stock Option (right to buy) | Common Stock (12,500) | $7.50 | May 4, 2030 | 12,500 | Acquired |
| May 4, 2020 | AWRE | Stock Option (right to buy) | Common Stock (12,500) | $6.50 | May 4, 2030 | 12,500 | Acquired |
| May 4, 2020 | AWRE | Stock Option (right to buy) | Common Stock (12,500) | $5.50 | May 4, 2030 | 12,500 | Acquired |
| May 4, 2020 | AWRE | Stock Option (right to buy) | Common Stock (12,500) | $4.50 | May 4, 2030 | 12,500 | Acquired |
| May 4, 2020 | AWRE | Unrestricted Stock Award | Common Stock (12,500) | $0.00 | — | 12,500 | Acquired |
| March 27, 2020 | AWRE | Unrestricted Stock Award | Common Stock (25,000) | $0.00 | — | 25,000 | Acquired |
| Nov. 19, 2019 | AWRE | Stock Option (right to buy) | Common Stock (18,750) | $7.50 | Nov. 19, 2029 | 18,750 | Acquired |
| Nov. 19, 2019 | AWRE | Stock Option (right to buy) | Common Stock (18,750) | $6.50 | Nov. 19, 2029 | 18,750 | Acquired |
| Nov. 19, 2019 | AWRE | Stock Option (right to buy) | Common Stock (18,750) | $5.50 | Nov. 19, 2029 | 18,750 | Acquired |
| Nov. 19, 2019 | AWRE | Stock Option (right to buy) | Common Stock (18,750) | $4.50 | Nov. 19, 2029 | 18,750 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $311,469 | — | — | — | — | — | $11,294 | $322,763 |
| 2024 | $303,908 | — | — | — | $31,865 | — | $11,386 | $468,825 |
| 2023 | $292,793 | — | — | — | $124,747 | — | $9,937 | $427,477 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.